Matricelf Ltd (MTLF) - Cash Flow Conversion Efficiency

Latest as of June 2025: -997.589x

Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million ≈ $-22.18K USD) by net assets (ILA8.29K ≈ $22.24 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MTLF net asset quality index to measure how much of total assets are equity-financed.

Matricelf Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore MTLF cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Matricelf Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Amanet Management & Systems Ltd
TA:AMAN
0.066x
Pergamon Status Dis Ticaret AS
IS:PSDTC
-0.002x
Caspin Resources Ltd
AU:CPN
-0.288x
Retractable Technologies Inc
NYSE MKT:RVP
-0.008x
Higher Way Electronic Co Ltd
TWO:3268
-0.040x
Nanollose Ltd
AU:NC6
6.134x
Kingston Resources Ltd
AU:KSN
0.081x
Holista Colltech Ltd
AU:HCT
-0.382x

Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)

The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Matricelf Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ILA15.17 Million
≈ $40.66K
ILA-11.75K
≈ $-31.51
-0.001x -98.09%
2023-12-31 ILA26.80 Million
≈ $71.86K
ILA-10.49K
≈ $-28.12
0.000x +99.83%
2022-12-31 ILA35.79 Million
≈ $95.96K
ILA-8.30 Million
≈ $-22.25K
-0.232x +8.20%
2021-12-31 ILA26.23 Million
≈ $70.32K
ILA-6.62 Million
≈ $-17.76K
-0.253x +79.57%
2020-12-31 ILA2.80 Million
≈ $7.50K
ILA-3.46 Million
≈ $-9.27K
-1.236x -1354.61%
2019-12-31 ILA3.62 Million
≈ $9.71K
ILA-307.80K
≈ $-825.19
-0.085x --

About Matricelf Ltd

TA:MTLF Israel Biotechnology
Market Cap
$20.84 Million
ILA7.77 Billion ILA
Market Cap Rank
#24946 Global
#359 in Israel
Share Price
ILA265.80
Change (1 day)
+1.80%
52-Week Range
ILA204.30 - ILA785.80
All Time High
ILA1480.00
About

Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more